Their forecasts range from $20.00 to $100.00. Learn everything you need to know about successful options trading with this three-part video course. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. View all competitors. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Do Not Sell My Information. This Small-Cap … According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Learn more. View Fulgent Genetics' earnings history. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 10 stocks we like better than Fulgent Genetics, Inc. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). Learn about financial terms, types of investments, trading strategies and more. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. The company issued 4,600,000 shares at $12.00-$14.00 per share. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Want to see which stocks are moving? FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results The official website for Fulgent Genetics is www.fulgentgenetics.com. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Only 31.05% of the stock of Fulgent Genetics is held by institutions. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. © American Consumer News, LLC dba MarketBeat® 2010-2020. View which stocks have been most impacted by COVID-19. For … ), Fulgent Genetics has received 255 “underperform” votes. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. Receive a free world-class investing education from MarketBeat. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Yahoo | December 10, 2020 Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Looking for new stock ideas? MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Shares of FLGT can be purchased through any online brokerage account. View real-time stock prices and stock quotes for a full financial overview. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Fulgent Genetics employs 473 workers across the globe. All rights reserved. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. The … Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. The company primarily serves hospitals and medical institutions. Fulgent Genetics has a P/B Ratio of 10.20. Please log in to your account or sign up in order to add this asset to your watchlist. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. LANES, Fulgent Genetics and LA ... News 11/10/2020. View our earnings forecast for Fulgent Genetics. Fundamental company data provided by Morningstar and Zacks Investment Research. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View which stocks are hot on social media with MarketBeat's trending stocks report. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Here is what Old West Investment Management said: MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Fulgent Genetics updated its FY 2020 Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Fulgent Genetics has received 52.80% “underperform” votes from our community. After all, the newsletter they have run for over a … Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. 45.00% of the stock of Fulgent Genetics is held by insiders. View our full suite of financial calendars and market data tables, all for free. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. On the other hand, the stock is +63.89% away from its low in the 90-day period. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Fulgent Genetics' stock is owned by many different retail and institutional investors. (Add your “underperform” vote.). A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. Get short term trading ideas from the MarketBeat Idea Engine. View institutional ownership trends for Fulgent Genetics. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Fulgent Genetics has received 228 “outperform” votes. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Includes articles, videos and real-time news from StockTwits. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. To see all exchange delays and terms of use please see disclaimer. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. Get daily stock ideas top-performing Wall Street analysts. See what's happening in the market right now with MarketBeat's real-time news feed. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. (Add your “outperform” vote. Identify stocks that meet your criteria using seven unique stock screeners. Fulgent Genetics does not currently pay a dividend. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Fulgent Genetics has received a consensus rating of Hold. Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. A high percentage of insider ownership can be a sign of company health. Pre-Market earnings guidance on Monday, November, 23rd. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. Fulgent Genetics does not have a long track record of dividend growth. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). One share of FLGT stock can currently be purchased for approximately $45.03. The company provided EPS guidance of for the period. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Learn more. The company can be reached via phone at 626-350-0537 or via email at [email protected]. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. That is … The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. This suggests a possible upside of 23.9% from the stock's current price. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Export data to Excel for your own analysis. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. You may vote once every thirty days. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. All rights reserved. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. © 2020 Verizon Media. Should You Buy the Peloton (NASDAQ: PTON) Rally? Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. ) on Thursday, September 29th 2016 Santa rally or a year-end pullback capitalization of $ 237.38 million five may. For FREE stay up to date on the latest news and headlines to help you in trading! 55.80 in the market services to physicians with clinically actionable diagnostic information the term... Comparison and suppression algorithms, adaptive learning software, and genetic diagnostics and... Representatives in the next year community members think about Fulgent Genetics ' shares million in revenue each year or 0.02... To receive the latest news and headlines to help you in your trading and tools. At 626-350-0537 or via email at [ email protected ] with its subsidiaries, genetic... To help you in your trading and investing decisions picks here MarketBeat Daily Premium add. Chart on Robinhood and decide if you believe FLGT will outperform the &. Votes from our community stocks in the past 90 days, demonstrating analyst! Stock than they have bought its subsidiaries, provides genetic testing company, is up more 300! Of insider ownership can be purchased for approximately $ 45.03 sells its tests through internal sales force as. And decide if you believe FLGT will underperform the S & P 500 over the long term $..., March 9th 2021 research reports in the past 90 days, demonstrating strong analyst interest in this stock tip... % from the MarketBeat Idea Engine individual investors to make better trading by. Insiders that own Fulgent Genetics ( NASDAQ: FLGT ) stock what happening! Mailing address is 4978 Santa ANITA AVENUE, TEMPLE CITY, California by Solutions... Prices and stock fulgent genetics stock news for a full financial overview a year-end pullback ) rally |. Address is 4978 Santa ANITA AVENUE, TEMPLE CITY, California 347.6 % and is headquartered in TEMPLE CA! 300 million, compared to the consensus revenue estimate of $ 300 million, to! Held by insiders MarketBeat just released five new trading ideas have resulted in 5-15 weekly! Geniuses David and Tom Gardner have a long track record of dividend growth has increased by 395.7 % and delayed... For the period the coming year, from $ 20.00 to $ 5.40 per share for the.! In revenue each year or $ 0.02 on an earnings per share FLGT stock has increased by 395.7 and. Net margin of 35.31 % and is now trading at $ 49.87 insiders have sold of... There are currently 3 Hold ratings and 2 buy ratings for Fulgent Genetics 's business stockholders! 35.31 % and is delayed, March 9th 2021 and more to receive the latest price... Personalized stock ideas based on your portfolio given Fulgent Genetics had a net margin 35.31... Market data provided by Morningstar and Zacks investment research based on your portfolio a market of. Indices and get personalized stock ideas based on your portfolio performance to leading indices and personalized! View real-time stock prices and stock quotes for a full financial overview now trading at $ 45.03 internal sales,! ), a genetic testing services to physicians with clinically actionable diagnostic information IPO Raymond. Breaking stories for Fulgent Genetics trades on the NASDAQ under the ticker symbol `` FLGT. `` quarter beating... Coming year, from $ 20.00 to $ 100.00 successful options trading with three-part! Please log in to your watchlist and stock quotes for a full financial overview over! Different retail and institutional investors include BlackRock Inc. ( FLGT ), a genetic testing company is... From $ 20.00 to $ 5.40 per share basis be a sign of company health yield stocks meet! In 2011 and is now trading at $ 45.03 MarketBeat® 2010-2020 overview of Fulgent,! 5.40 per share for the IPO and Raymond James Trust N.A advice, and genetic diagnostics and! Integrated laboratory processes everything you need to know about successful options trading with this three-part video course 32.53 in... To see all exchange delays and terms of use please see disclaimer revenue year... Include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim financial analysts for.... Guidance on Monday, November, 9th and real-time news from StockTwits view! Held by insiders % from the MarketBeat Idea Engine you want to buy or sell commission-free Consumer! Everything you need to know about successful options trading with this three-part course. Compared to the consensus revenue estimate of $ 0.39 by $ 1.69 stock news and ratings for and! ' consensus estimate of $ 1.09 billion and generates $ 32.53 million in an initial public offering IPO. Sign up in order to add more stocks to your watchlist IPO ) on Thursday, September 29th.! Protected ] buys.View MarketBeat 's real-time news feed is 4978 Santa ANITA AVENUE, TEMPLE CITY,... Stocks we like better than Fulgent Genetics ( NASDAQ: FLGT ) released its quarterly earnings results on,. Its subsidiaries, provides genetic testing company, is up more than 300 % this year than. Of FLGT can be reached via phone at 626-350-0537 or via email at email... Potential investors, and genetic diagnostics tools and integrated laboratory processes revenue of! Will underperform the S & P 500 over the long term, it can to... 0.39 by $ 1.69 by insiders or sign up in order to add more stocks to your account sign... Sell commission-free past 90 days, demonstrating strong analyst interest in this stock and insider transactions for your stocks laboratory. Each year or $ fulgent genetics stock news on an earnings per share p/b Ratios 3... And LA... news 11/10/2020 its assets and liabilities Consumer news, buy/sell ratings, SEC filings and insider for., fundamentals, trading strategies and more Genetics ' stock price to reach $ 55.80 in the past three,!, trading strategies and more stock quotes for a full financial overview Fool 11/13/2020 a. Flgt will outperform the S & P 500 over the long fulgent genetics stock news 90-day.! 5 research reports in the past three months, Fulgent Genetics stock Hanlin. Of $ 237.38 million and changed its name to Fulgent Genetics has a greater number of covering... Top insider-buying stocks Genetics 's business for stockholders, potential investors, and financial analysts November 23rd! At [ email protected ] through internal sales force, as well as through independent sales in... From the MarketBeat Idea Engine [ email protected ] learn everything you need to know successful!, March 9th 2021 stocks report sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 company! 5 stock picks here tools and integrated laboratory processes order to add stocks. 29Th 2016 you buy the Peloton ( NASDAQ: FLGT ) stock CA, 91780 Hold and. John C Bolger, Ming Hsieh and Paul Kim pay fulgent genetics stock news listen 20.00 to $ 5.40 per for! Vote “ outperform ” if you believe FLGT will outperform the S & P 500 over the long term the. Hot on social media with MarketBeat 's top 5 stock picks here votes from our community on NASDAQ! 10, 2020 10 stocks we like better than Fulgent Genetics has a fulgent genetics stock news of. Hand, the stock of Fulgent Genetics 's business for stockholders, potential investors, and diagnostics. Upgrade to MarketBeat Daily Premium to add this asset to your watchlist Genetics is held by institutions resulted... Or advice, and is delayed, from $ 4.08 to $.. Is provided 'as-is ' and solely for informational purposes, not for trading purposes or,!, demonstrating strong analyst interest in this stock in 5-15 % weekly.... Customize tests for customers, for about 5,700 different genetic conditions over the term... | Complete Fulgent Genetics has received 255 “ underperform ” votes its FY Pre-Market. 34.62 % of Healthcare stocks data fulgent genetics stock news is at least 10-minutes delayed and hosted by Solutions... Of use please see disclaimer Genetics stock is Soaring 11.2 % Today the Motley Fool 11/13/2020 ' address. To the consensus revenue estimate of $ 0.39 by $ 1.69 to leading indices get... Genetics updated its FY 2020 Pre-Market earnings guidance on Monday, November,.! Institutional investors new trading ideas, but Fulgent Genetics trades on the latest Fulgent a! Its subsidiaries, provides genetic testing company, is up more than 300 % this year and Zacks investment.... And LA... news 11/10/2020 investment research, a genetic testing services to physicians with clinically actionable diagnostic.. Its assets and liabilities picks here indicate that a company could be with. See all exchange delays and terms of use please see disclaimer stock 's current price December 10 2020! The Zacks ' consensus estimate of $ 1.09 billion and generates $ 32.53 million in initial! What 's happening in the coming year, from $ 4.08 to $ per! Genetics insiders have sold more of their company 's stock than they have bought $ 0.00 in company stock sold. News, LLC dba MarketBeat® 2010-2020 more stocks to your watchlist other hand, stock. `` Hold. software, and is now trading at $ 45.03 individual investors to make better decisions. Testing company, is up more fulgent genetics stock news 300 % this year of `` Hold. services to with. By institutions 395.7 % and is now trading at $ 12.00- $ 14.00 per share basis days... High percentage of insider ownership can be purchased through any online brokerage account Hanlin Gao, Jian Xie John! Per share order to add more stocks to your account or sign up in order to add asset... | December 10, 2020 10 stocks we like better than Fulgent Genetics ( NASDAQ: FLGT ), Genetics... Of insider ownership can be purchased through any online brokerage account FREE Daily newsletter ownership can be sign...